ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Takeda Pharmaceutical has opened a contract research firm, Axcelead, that provides drug discovery and development services to Takeda as well as other firms. Located in Kanagawa, Japan, near Tokyo, Axcelead is made up of assets and employees transferred from Takeda. It will offer preclinical services from basic research to compound optimization. Takeda says it spun off the company to increase the focus and productivity of its core research unit. In February, Takeda transferred some of its process chemistry and formulation development operations to Bushu Pharmaceuticals, a Japanese contract manufacturer.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X